Austria Health Focus
SEE OTHER BRANDS

Fresh news on health and wellness in Austria

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.

Baby Pacifier Market Size to Reach USD 824.11 Million by 2034, Growing at 3.90% CAGR

Baby Pacifier Market Size to Reach USD 824.11 Million by 2034, Growing at 3.90% CAGR

The global baby pacifier market size was worth around USD 562.12 million in 2024 and is predicted to grow to around USD 824.11 million by 2034 PUNE, MAHARASHTRA, INDIA, September 10, 2025 /⁨EINPresswire.com⁩/ -- Executive Summary The global baby...

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies

PALM BEACH, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial Intelligence (AI) is becoming more essential in the medical markets every day, it seems. AI algorithms have demonstrated the capability to analyze vast...

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- F2G Ltd, a clinical-stage biopharmaceutical company developing olorofim, a novel therapy to treat life-threatening rare fungal infections with high unmet medical need, today announced...

Fallouh Healthcare wins funding to develop device providing early diagnosis of cardiac tamponade

Fallouh Healthcare wins funding to develop device providing early diagnosis of cardiac tamponade

Cardiac tamponade can come on quickly, diagnosis is difficult and subjective, and it can be confused with other sources of heart failure. BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, June 18, 2025 /⁨EINPresswire.com⁩/ -- Birmingham-based Fallouh...

Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation

Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation

Boston, June 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Disposable Ostomy Bags: Global Market” is projected to increase from $2.8 billion in 2024 to $3.7 billion by the end of 2031, at a compound annual...

University of Ioannina Launches Groundbreaking MSc in Digital Health in Greece

University of Ioannina Launches Groundbreaking MSc in Digital Health in Greece

The University of Ioannina proudly announces the launch of its cutting-edge, two-year full-time MSc program in Digital Health. IOANNINA, IOANNINA, GREECE, June 12, 2025 /⁨EINPresswire.com⁩/ -- University of Ioannina Launches Groundbreaking MSc in...

ePharmacy Market Will Hit Big Revenue In Future | BestKenko, Healthkart, PharmEasy

ePharmacy Market Will Hit Big Revenue In Future | BestKenko, Healthkart, PharmEasy

The Global ePharmacy Market is projected to grow from $98.5 Billion in 2025 to $460.8 Billion by 2034, at a CAGR of 18.7%. HYDERABAD, TELANGANA, INDIA, June 12, 2025 /⁨EINPresswire.com⁩/ -- USD Analytics just released the Global ePharmacy Market...

Amy Lawton Receives CEU’s 2025 European Award for Excellence in Teaching

Amy Lawton Receives CEU’s 2025 European Award for Excellence in Teaching

VIENNA , AUSTRIA, September 3, 2025 /⁨EINPresswire.com⁩/ -- Central European University (CEU) has awarded the fourteenth annual European Award for Excellence in Teaching in the Social Sciences and Humanities to Dr. Amy Lawton, Senior Lecturer in...

IASP 33rd World Congress Returns to Vienna to Mark 65 Years of Global Suicide Prevention Leadership

IASP 33rd World Congress Returns to Vienna to Mark 65 Years of Global Suicide Prevention Leadership

IASP will host its 33rd World Congress in Vienna, Austria, from 10–13 June 2025, marking a significant milestone: the organisation’s 65th anniversary. WASHINGTON DC, DC, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- IASP 33rd World Congress...

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the...

Generative Engine Optimization (GEO): The New Frontier of Digital Visibility

Generative Engine Optimization (GEO): The New Frontier of Digital Visibility

As consumers shift from Google to AI assistants like ChatGPT & Gemini, companies must embrace GEO (LLMO, GAIO) to remain discoverable. But how does it work? AUGSBURG, BAVARIA, GERMANY, September 9, 2025 /⁨EINPresswire.com⁩/ -- A radical change is...

Biomethane Market Growing at 6.08% CAGR to Reach USD 9.23 Billion by 2032 Maximize Market Research

Biomethane Market Growing at 6.08% CAGR to Reach USD 9.23 Billion by 2032 Maximize Market Research

The German biomethane market has emerged as a highly attractive sector due to its dynamic regulatory framework and evolving market conditions. WILMINGTON, DE, UNITED STATES, September 11, 2025 /⁨EINPresswire.com⁩/ -- Biomethane Industry Overview...

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human...

Sarfez Pharmaceuticals, Inc. - 708901 - 04/25/2025

Sarfez Pharmaceuticals, Inc. - 708901 - 04/25/2025

Recipient: Recipient Name Salim Shah, PhD, JD Recipient Title Founder/President/CEO Sarfez Pharmaceuticals, Inc. 8000 Towers Crescent Drive Suite 1302 Vienna, VA 22182 United States Issuing Office: Center for Drug Evaluation and Research (CDER)...

Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences

Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences

Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii), which was developed using Azymetric™, to be...

Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025

Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025

BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a...

Exergen Appoints Paula McGrane as New European Commercial Director to Support Growth and Adoption 

Exergen Appoints Paula McGrane as New European Commercial Director to Support Growth and Adoption 

Paula McGrane joins Exergen as Commercial Director for Europe with extensive medical sales and strategic business planning and experience. WATERTOWN, MA, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- Exergen Corporation, a leading...

Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM)

Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM)

Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ RNA sequencing data show early tumor apoptosis and activation of innate immune responses Updated ReSPECT data presented at the 2025 Nuclear Medicine and...

Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board

Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit affirmed-in-part and vacated-in-part the Patent...

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions